These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5665748)

  • 41. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hypofibrinolysis in acute myocardial infarction (author's transl)].
    Bruhn HD; Jipp P; Okoye S; Oltmann A
    Med Klin; 1974 Nov; 69(47):1951-5. PubMed ID: 4444662
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pharmacologic principles of fibrinolytic therapy].
    Markwardt F
    Z Gesamte Inn Med; 1987 Sep; 42(17):473-8. PubMed ID: 3318182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Intravital fibrinolytic effect of a new beta-blocking adrenergic drug (INPEA)].
    Colla G; Dallavalle L; Debiasi D; Starcich R
    Boll Soc Ital Biol Sper; 1966 Jun; 42(12):788-90. PubMed ID: 5973341
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of aggregation of human and rat platelets by fibrinolytic drug phenformin.
    Kovács IB; Csalay L; Görög P
    Angiology; 1972 Apr; 23(4):223-7. PubMed ID: 5030558
    [No Abstract]   [Full Text] [Related]  

  • 46. Monitoring activity of fibrinolytic agents.
    Gilkey FW
    Am J Med; 1985 Feb; 78(2):A44, A46. PubMed ID: 3970044
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug-induced alterations of hemostasis and fibrinolysis.
    Fareed J; Hoppenstedt D; Bick RL; Bacher P
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1229-45. PubMed ID: 1452510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Change in the blood coagulating and fibrinolytic systems in diabetic retinopathy and its treatment with anticoagulant and fibrinolytic preparations].
    Mikhaĭlova NA; Tartakovskaia AI
    Vestn Oftalmol; 1972; 5():88-91. PubMed ID: 4667907
    [No Abstract]   [Full Text] [Related]  

  • 49. Tissue-plasminogen activator fibrinolysis.
    Osher RH
    J Cataract Refract Surg; 1999 Jul; 25(7):880. PubMed ID: 10404358
    [No Abstract]   [Full Text] [Related]  

  • 50. A study of the possible effects of drugs on fibrinolytic activity in vitro.
    Menon IS
    Lab Pract; 1967 Sep; 16(9):1096-7. PubMed ID: 6074063
    [No Abstract]   [Full Text] [Related]  

  • 51. [Fibrinolysis and thrombolytic drugs].
    Seifried E
    Internist (Berl); 1992 Apr; 33(4):197-205. PubMed ID: 1612843
    [No Abstract]   [Full Text] [Related]  

  • 52. [Regulation of fibrinolysis and anti-fibrinolytic activity of the serum in children].
    Alekseenko IF
    Sov Zdravookhr Kirg; 1969; 6():18-22. PubMed ID: 5375017
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of tricholysine on plasma fibrinolytic activity].
    Serebriakova TN; Andreenko GV; Maksimova RA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (8):46-51. PubMed ID: 7196773
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M; Myśliwiec M; Perzanowski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmacologic fibrinolysis: a new concept for study of antiinflammatory drugs].
    Tubaro E
    Boll Chim Farm; 1965 Jul; 104(7):395-6. PubMed ID: 5843460
    [No Abstract]   [Full Text] [Related]  

  • 56. Fibrinolysis and deep-vein thrombosis.
    Lancet; 1969 May; 1(7601):931-2. PubMed ID: 4180907
    [No Abstract]   [Full Text] [Related]  

  • 57. [Synthetic compounds with fibrinolytic and thrombolytic activity. 2. Studies on mode of action].
    Desnoyers P; Samama M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):357-62. PubMed ID: 63422
    [No Abstract]   [Full Text] [Related]  

  • 58. Fibrinolytic therapy: biochemical mechanisms.
    Robbins KC
    Semin Thromb Hemost; 1991 Jan; 17(1):1-6. PubMed ID: 1828622
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis].
    Van de Loo J
    Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current developments in fibrinolytic therapy].
    Rijken DC
    Ned Tijdschr Geneeskd; 1985 Sep; 129(37):1768-72. PubMed ID: 3934567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.